Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2019

01-08-2019 | Original Article

Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT

Authors: Ismaheel O. Lawal, MD, Alfred O. Ankrah, MD, Gbenga O. Popoola, MD, Thabo Lengana, MD, Mike M. Sathekge, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2019

Login to get access

Abstract

Background

HIV infection is associated with the risk of development of atherosclerosis at a younger age. We compared arterial inflammation in HIV-infected and HIV-uninfected patients with otherwise low-risk factors for cardiovascular disease (CVD) using FDG PET/CT.

Methods

242 patients aged 18–40 years with low-risk factors for CVD consisting of 121 HIV-infected patients and 121 HIV-uninfected age- and gender-matched controls were studied, mean age = 34.95 ± 5.46 years. We calculated and compared the target-to-background ratio of FDG uptake in ascending aorta of HIV-infected and non-infected patients.

Results

Median CD4 count and viral load were 375.5 cells/mm3 (range 2-1094) and 6391.00 copies/mL (range 24-1,348,622), respectively. There was slightly higher but significant overlap in the TBR between HIV-infected group compared with control (1.22, 0.87-2.02 vs. 1.12, 0.38-1.40, P < 0.001). TBR was neither affected by CD4 count levels nor the presence or absence of detectable viremia. We also found no significant difference in TBR between male and female patients with HIV infection. We found a weak positive correlation between TBR and CD4 count, TBR and duration of HIV infection, and a very weak negative correlation between TBR and viral load. There was no significant difference in TBR between patients on HAART and those not yet commenced on therapy.

Conclusion

Marginally higher TBR with a significant overlap exist in HIV-infected patients compared with control. Arterial F-18 FDG uptake is not affected by the CD 4 count, viral load, gender, or duration of HIV infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: The Global of Disease Study 2015. Lancet HIV. 2016;3:e361–87.CrossRef Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: The Global of Disease Study 2015. Lancet HIV. 2016;3:e361–87.CrossRef
3.
go back to reference Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24:1228–30.CrossRefPubMed Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24:1228–30.CrossRefPubMed
4.
go back to reference Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis. HIV Med. 2012;13:453–68.PubMed Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis. HIV Med. 2012;13:453–68.PubMed
6.
go back to reference Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull. 2016;120:55–74.CrossRefPubMed Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull. 2016;120:55–74.CrossRefPubMed
7.
go back to reference Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment of FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24:413–24.CrossRefPubMed Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment of FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24:413–24.CrossRefPubMed
8.
10.
go back to reference Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, et al. HIV and coronary artery disease: time for better understanding. J Am Coll Cardiol. 2013;61:511–23.CrossRefPubMed Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, et al. HIV and coronary artery disease: time for better understanding. J Am Coll Cardiol. 2013;61:511–23.CrossRefPubMed
11.
go back to reference Lawal I, Lengana T, Ololade K, Boshomane T, Reyneke F, Modiselle M, et al. 18F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence. Nuklearmedizin. 2017;56:83–9.CrossRefPubMed Lawal I, Lengana T, Ololade K, Boshomane T, Reyneke F, Modiselle M, et al. 18F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence. Nuklearmedizin. 2017;56:83–9.CrossRefPubMed
12.
go back to reference Knudsen A, Hag AMF, Loft A, von Benzon E, Keller SH, MØller HJ, et al. HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study. J Nucl Cardiol. 2015;25:372–80.CrossRef Knudsen A, Hag AMF, Loft A, von Benzon E, Keller SH, MØller HJ, et al. HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study. J Nucl Cardiol. 2015;25:372–80.CrossRef
13.
go back to reference Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818–24.CrossRef Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818–24.CrossRef
14.
go back to reference Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, et al. Effects of statin therapy on coronary artery plaque volume and high risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomized double-blind placebo-controlled trial. Lancet HIV. 2015;2:e52–63.CrossRefPubMedPubMedCentral Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, et al. Effects of statin therapy on coronary artery plaque volume and high risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomized double-blind placebo-controlled trial. Lancet HIV. 2015;2:e52–63.CrossRefPubMedPubMedCentral
15.
go back to reference Lawal I, Zeevaart JR, Ebenhan T, Ankrah A, Vorster M, Kruger H, et al. Metabolic imaging of infection. J Nucl Med. 2017;58(11):1727–32.CrossRefPubMed Lawal I, Zeevaart JR, Ebenhan T, Ankrah A, Vorster M, Kruger H, et al. Metabolic imaging of infection. J Nucl Med. 2017;58(11):1727–32.CrossRefPubMed
16.
go back to reference Zanni MV, Toribio M, Robbins GK, Burdo TH, Lu MT, Ishai AE, et al. Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naïve patients with human immunodeficiency virus infection. JAMA Cardiol. 2016;1:474–80.CrossRefPubMedPubMedCentral Zanni MV, Toribio M, Robbins GK, Burdo TH, Lu MT, Ishai AE, et al. Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naïve patients with human immunodeficiency virus infection. JAMA Cardiol. 2016;1:474–80.CrossRefPubMedPubMedCentral
17.
go back to reference Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, et al. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging. 2014;41:369–83.CrossRefPubMed Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, et al. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging. 2014;41:369–83.CrossRefPubMed
Metadata
Title
Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT
Authors
Ismaheel O. Lawal, MD
Alfred O. Ankrah, MD
Gbenga O. Popoola, MD
Thabo Lengana, MD
Mike M. Sathekge, MD, PhD
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1207-x

Other articles of this Issue 4/2019

Journal of Nuclear Cardiology 4/2019 Go to the issue